Pyr-Phe-Trp-Lys-Tyr-OH
|
|
|
Pyr-Phe-OH
|
|
21282-12-2
|
Pyr-Leu-Leu-Gly-Gly-Arg-Phe-Gly-Tyr-OH
|
|
|
Pyr-Gly-OH
|
|
29227-88-1
|
Pyr-Gly-Gly-Leu-Arg-Trp-NH2
|
|
328085-50-3
|
Pyr-Phe-Leu-pNA
|
|
85901-57-1
|
Pyr-Pro-Arg-pNA hydrochloride salt
|
|
72194-57-1
|
Pyr-Phe-Gly-NH2
|
|
203396-25-2
|
Peptide WE-14
|
|
115136-18-0
|
Peptitergent PD1
|
|
|
Pepzyme
|
|
|
Protein G B1 Domain (41-56)
|
|
160291-75-8
|
Preangiotensinogen (11-14) (human) acetate salt
|
|
102813-98-9
|
Phospholipase A2 Activating Peptide
|
|
137314-60-4
|
Protein Fragment (187-204)
|
|
|
Prepro-Nerve Growth Factor (99-115) (mouse)
|
|
|
Pheromone Biosynthesis Activating Neuropeptide (Helicoverpa assulta, Heliothis zea)
|
|
122071-54-9
|
Pyr-Gln-OH
|
|
109481-23-4
|
Pol-RFamide
|
|
119116-89-1
|
Pyr-Arg-Thr-Lys-Arg-AMC trifluoroacetate salt
|
|
155575-02-3
|
Pyr-Ala-OH
|
|
21282-08-6
|
Phenylac-Gly-Lys-OH
|
|
113969-25-8
|
p-Hydroxy-Bz-Ala-Phe-OH
|
|
92279-13-5
|
Phylloseptin-L2
|
|
1100546-22-2
|
Proctolin
|
|
57966-42-4
|
Pheromonotropin (Pseudaletia separata)
|
|
|
Phospholipase A2 Fragment (70-74)
|
|
147139-72-8
|
Perisulfakinin
|
|
125131-58-0
|
Inactivation Gate Peptide
|
|
156162-44-6
|
H-Val-Val-Val-NH2
|
|
|
H-Val-Val-Val-OH
|
|
28130-13-4
|
H-β-Ala-Leu-OH
|
|
17136-25-3
|
H-β-Ala-Trp-OH
|
|
21612-37-3
|
H-β-Ala-Phe-OH
|
|
17136-28-6
|
Hypertrehalosaemic Neuropeptide (Heliothis zea)
|
|
117107-54-7
|
H-Val-β-Ala-OH
|
|
30806-08-7
|
Hypertrehalosaemic Neuropeptide (Nauphoeta cinerea)
|
|
106018-36-4
|
H-Val-Val-Val-Val-OH
|
|
64577-64-6
|
H-Val-Val-Lys-OH
|
|
73015-99-3
|
H-β-Ala-Gly-Gly-OH
|
|
|
H-β-Ala-Lys-OH · HCl
|
|
90970-40-4
|
H-β-Ala-Gly-Ala-OH
|
|
|
Influenza PR8 Hemagglutinin Peptide (110-119) trifluoroacetate salt
|
|
132031-50-6
|
Hymenistatin I
|
|
129536-23-8
|
Intermedin-53 (human)
|
|
1140977-96-3
|
Insulin Receptor (689-702)
|
|
|
H-Val-Val-Phe-OH
|
|
153247-47-3
|
H-Val-Val-OH
|
|
3918-94-3
|
H-β-Ala-Val-OH
|
|
17136-26-4
|
H-β-Ala-β-Ala-β-Ala-OH
|
|
69010-59-9
|
H-Val-Val-Gln-OH
|
|
212207-62-0
|
H-Val-Tyr-Ser-βNA hydrochloride salt
|
|
13989-68-9
|
H-Val-Tyr-Val-OH
|
|
17355-22-5
|
Lysozyme C (46-61) (chicken) trifluoroacetate salt
|
|
62982-31-4
|
Matrix Protein M1 (58-66) (Influenza A virus) acetate salt
|
|
141368-69-6
|
N-[(RS)-1-Carboxy-3-phenyl-propyl]-Ala-Ala-Phe-4-Abz-OH trifluoroacetate salt
|
|
116560-97-5
|
Lys-Thymic Factor trifluoroacetate salt
|
|
318950-01-5
|
M65 trifluoroacetate salt
|
|
1872440-65-7
|
NFAT Inhibitor trifluoroacetate salt
|
|
249537-73-3
|
Nocistatin (bovine) trifluoroacetate salt
|
|
208253-85-4
|
Macrophage Inhibitory Peptide
|
|
41961-56-2
|
Neuropeptide GE
|
|
134748-04-2
|
L-Ornithine-L-aspartate salt
|
L-鳥(niǎo)氨酸-L-天門冬氨酸鹽
|
3230-94-2
|
Leukotriene A4 (LTA4) Hydrolase (365-385) (human)
|
|
|
Litorin
|
|
55749-97-8
|
Locustakinin I
|
|
139602-08-7
|
LIP2 (human)
|
|
1872440-46-4
|
Lymphocyte Activating Pentapeptide
|
|
120484-65-3
|
Locustamyotropin IV
|
|
143907-81-7
|
LIP1 (human) trifluoroacetate salt
|
|
1872435-03-4
|
LymnaDFamide-1
|
|
148596-98-9
|
Levitide
|
|
114281-19-5
|
Leech Osmoregulatory Factor
|
|
175413-77-1
|
Lactoferrin N-Lobe (231-245) (human)
|
|
169056-32-0
|
Kemptamide trifluoroacetate salt
|
|
89315-28-6
|
Kentsin
|
|
56767-30-7
|
KALA Amphipathic Peptide
|
|
|
Isovaleryl-Phe-Lys-pNA · HCl
|
|
178894-43-4
|
Peptide M
|
|
110652-62-5
|
Peptide 6A
|
|
73549-32-3
|
Osteopontin (131-137) (mouse)
|
|
577725-62-3
|
Peptide 74
|
|
132116-39-3
|
Peptide 810
|
|
156371-22-1
|
Orcokinin
|
|
145344-97-4
|
Peptide 46
|
|
192122-40-0
|
Pedibin Precursor (hydra)
|
|
|
Opiorphin trifluoroacetate salt
|
|
864084-88-8
|
Ophthalmic Acid
|
|
495-27-2
|
H-Val-Trp-Ile-OH
|
|
|
H-Val-Leu-Ser-OH
|
|
|
H-Val-Lys-OH
|
|
22677-62-9
|
H-Val-Pro-OtBu
|
|
60108-51-2
|
H-Val-Met-OH
|
|
14486-09-0
|
H-Val-Tyr-NH2
|
|
126712-17-2
|
H-Val-Lys-Lys-Arg-OH
|
|
286471-39-4
|
H-Val-Ser-OH
|
|
13588-94-8
|
H-Val-Pro-OH
|
|
105931-64-4
|
H-Val-Tyr-Pro-OH
|
|
68076-97-1
|
H-Val-Phe-OH
|
|
3918-92-1
|
H-Val-Phe-NH2
|
|
129678-27-9
|